TMO Thermo Fisher Scientific Inc.
Healthcare$448.28-0.24%ClosedMarket Cap: $166.59B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$638.20
Target (Median)
$644.50
Target Range
$490.00 - $750.00
Upside from current price: 42.4%
Rating Distribution
5 Strong Buy19 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-24 | Baird | maintain | Outperform | Outperform |
| 2026-04-24 | Stifel | maintain | Buy | Buy |
| 2026-04-14 | Barclays | maintain | Overweight | Overweight |
| 2026-04-06 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-01-30 | TD Cowen | maintain | Buy | Buy |
| 2026-01-30 | Barclays | maintain | Overweight | Overweight |
| 2026-01-30 | Citigroup | maintain | Buy | Buy |
| 2026-01-09 | Stifel | maintain | Buy | Buy |
| 2025-12-15 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $27.24 | $50.40B | 14 |
| Sun Dec 31 | $30.05 | $53.57B | 4 |
| Mon Dec 31 | $33.78 | $56.47B | 2 |
| Tue Dec 31 | $37.78 | $58.18B | 2 |